Taiwan FDA registration a7fc296ff3bd73f2dda31ebc0f26ca8a
"100 first" insulin radioimmunoassay reagents
TW: “百首” 胰島素放射免疫分析試劑
Taiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Feb 26, 2010 – Feb 26, 2025ExpiredRegistration details
- Analysis ID
- a7fc296ff3bd73f2dda31ebc0f26ca8a
- Customs Code
- DHAS0602083202
Company information
- Manufacturer
- DIASOURCE IMMUNOASSAYS S.A.
- Manufacturer Country
- Belgium
- Authorized Representative
- TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
- Intended Use
- Insulin (INS) radioimmunoassay reagent for in vitro quantitative detection of human serum.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1405 Immune Response Insulin Test System
- Import Information
- Imports must be accompanied by a letter of consent (a certificate of approval of the Atomic Energy Commission shall be attached to each batch of imports); input
Dates and status
- Registration Date
- Feb 26, 2010
- Expiry Date
- Feb 26, 2025
About this record
Access comprehensive regulatory information for "100 first" insulin radioimmunoassay reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a7fc296ff3bd73f2dda31ebc0f26ca8a and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices